Accueil / Tag Archives: Ipo

Tag Archives: Ipo

Seres Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

Wednesday, June 12th 2019 at 8:07pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres”), a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome, today announced that it is commencing an …

Plus »

BridgeBio Pharma Announces Filing of Registration Statement for Proposed Initial Public Offering

Friday, May 24th 2019 at 9:09pm UTC PALO ALTO, Calif.–(BUSINESS WIRE)– BridgeBio Pharma, Inc., a clinical-stage biopharmaceutical company focused on genetic diseases, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of …

Plus »

Bicycle Therapeutics Announces Pricing of Initial Public Offering

Thursday, May 23rd 2019 at 1:49am UTC CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)– Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, today announced the pricing of its initial public offering in the United States of 4,333,333 …

Plus »

Gossamer Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Tuesday, February 12th 2019 at 9:05pm UTC SAN DIEGO–(BUSINESS WIRE)– Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced the closing of its previously announced initial public offering of 19,837,500 shares of …

Plus »

Harpoon Therapeutics Announces Pricing of Initial Public Offering

Friday, February 8th 2019 at 12:34am UTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Harpoon Therapeutics, Inc. (“Harpoon”), a clinical-stage immunotherapy company developing a novel class of T cell engagers, announced today the pricing of its initial public offering of 5,400,000 shares of its common stock at a price to the public …

Plus »

Gossamer Bio Announces Pricing of Initial Public Offering

Thursday, February 7th 2019 at 11:17pm UTC SAN DIEGO–(BUSINESS WIRE)– Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced the pricing of its initial public offering of 17,250,000 shares of common …

Plus »

Alector Announces Pricing of Initial Public Offering

Thursday, February 7th 2019 at 12:59am UTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Alector, Inc. (Nasdaq: ALEC), a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the pricing of its initial public offering of 9,250,000 shares of common stock to the public …

Plus »

Gossamer Bio Announces Updates Regarding its Initial Public Offering

Wednesday, January 30th 2019 at 10:09pm UTC SAN DIEGO–(BUSINESS WIRE)– Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it has filed an amended registration statement on Form S-1 with the U.S. …

Plus »

Gossamer Bio Announces Commencement of Initial Public Offering

Wednesday, January 23rd 2019 at 10:24pm UTC SAN DIEGO–(BUSINESS WIRE)– Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities …

Plus »

FSD Pharma Congratulates Cannara Biotech for Its Listing and Commencement of Trading on the CSE

Monday, January 14th 2019 at 1:00pm UTC TORONTO–(BUSINESS WIRE)– FSD Pharma Inc. (« FSD » or the « Company ») (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) would like to congratulate Cannara Biotech Inc. (“Cannara”) for its listing approval and commencement of trading on the Canadian Securities Exchange (« CSE ») today under the stock symbol « LOVE ». …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.